Please login to the repository to save this object to your list.
Cite this document
Tomić, D. (2021). Results of the efficacy of FDA approved antiviral drugs on SARS-CoV-2 spike glycoprotein [Data set]. https://urn.nsk.hr/urn:nbn:hr:241:733364.
Tomić, Draško. Results of the efficacy of FDA approved antiviral drugs on SARS-CoV-2 spike glycoprotein. Institut Ruđer Bošković, 2021. 30 Oct 2024. https://urn.nsk.hr/urn:nbn:hr:241:733364.
Tomić, Draško. 2021. Results of the efficacy of FDA approved antiviral drugs on SARS-CoV-2 spike glycoprotein. Institut Ruđer Bošković. https://urn.nsk.hr/urn:nbn:hr:241:733364.
Tomić, D. 2021. Results of the efficacy of FDA approved antiviral drugs on SARS-CoV-2 spike glycoprotein. Institut Ruđer Bošković. [Online]. [Accessed 30 October 2024]. Available from: https://urn.nsk.hr/urn:nbn:hr:241:733364.
Tomić D. Results of the efficacy of FDA approved antiviral drugs on SARS-CoV-2 spike glycoprotein. [Internet]. Institut Ruđer Bošković: , HR; 2021, [cited 2024 October 30] Available from: https://urn.nsk.hr/urn:nbn:hr:241:733364.
D. Tomić, Results of the efficacy of FDA approved antiviral drugs on SARS-CoV-2 spike glycoprotein, Institut Ruđer Bošković, 2021. Accessed on: Oct 30, 2024. Available: https://urn.nsk.hr/urn:nbn:hr:241:733364.
These results were obtained using the Vini in silico model of cancer in the period from March to December 2020. The efficacy of 49 FDA-approved antiviral drugs on SARS-CoV-2 spike glycoprotein was analyzed. Based on the fact that HIV drugs showed the highest efficacy, the efficacy of their double and triple combinations was further calculated.
Methods (english)
These results were obtained using the Vini in silico model of cancer in the period from March to December 2020. The efficacy of 49 FDA-approved antiviral drugs on SARS-CoV-2 spike glycoprotein has analyzed with the Vini in silico model of cancer. Based on the fact that HIV drugs showed the highest efficacy, the efficacy of their double and triple combinations was further calculated. Finally, 10 most effective HIV drug combinations were finally examined on their possible adverse effects with Medscape and Lexicomp software.
Number: KK.01.1.1.01.009 Title (croatian): Napredne metode i tehnologije u znanosti o podatcima i kooperativnim sustavima-DATACROSS Acronym: DATACROSS Leader: Sven Lončarić; Petrović Ivan Jurisdiction: eu